Rchr
J-GLOBAL ID：200901067086438327
Update date: Apr. 22, 2024
Yamaguchi Kanji
ヤマグチ カンジ | Yamaguchi Kanji
Affiliation and department：
Research field (2)：
Gastroenterology
, Medical biochemistry
Research keywords (3)：
代謝学
, 消化器病学
, 肝臓病学
Research theme for competitive and other funds (10)：
- 2022 - 2025 Significance of Apg-2 in human NAFLD
- 2022 - 2025 The role of heat shock protein Apg-2 in hepatic lipogenesis and hepatocarcinogenesis by using liver organoids.
- 2019 - 2022 The role of heat shock protein Apg-2 in hepatic lipogenesis and hepatocarcinogenesis by the inhibition of lipophagy
- 2016 - 2019 The role of HSP110 family, Apg-2 in NASH-related hepatic lipid and glucose metabolism.
- 2015 - 2018 The role of Apg-2 in liver steatosis and carcinogenesis
- 2013 - 2016 Examination about the association between intrahepatic immunogenicity and the expression of regulatory molecules on hepatic T cells in mouse NASH model.
- 2008 - 2010 Studies on a role of a crosslinking enzyme, transglutaminase in pathogenesis of liver diseases
- 2008 - 2010 The effect of DGAT on liver steatosis, fibrosis and carcinogenesis in murine NASH models.
肝臓
- ウイルス
Show all
Papers (179)：
-
Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, et al. Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2024
-
Makoto Imamori, Tetsuya Hosooka, Yukiko Imi, Yusei Hosokawa, Kanji Yamaguchi, Yoshito Itoh, Wataru Ogawa. Thrombospondin-1 promotes liver fibrosis by enhancing TGF-β action in hepatic stellate cells. Biochemical and biophysical research communications. 2023. 693. 149369-149369
-
Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, Ryuichi Morita, Seita Kataoka, Hayato Miyake, Kanji Yamaguchi, Michihisa Moriguchi, Yoshio Sogame, Hiroaki Yasuda, et al. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database. Journal of gastroenterology. 2023
-
Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, et al. The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study. Liver International. 2023
-
Yusei Hosokawa, Tetsuya Hosooka, Makoto Imamori, Kanji Yamaguchi, Yoshito Itoh, Wataru Ogawa. Adipose tissue insulin resistance exacerbates liver inflammation and fibrosis in a diet-induced NASH model. Hepatology communications. 2023. 7. 6
ｍore...
MISC (198)：
-
片岡星太, 楳村敦詩, 瀬古裕也, 山口寛二, 森口理久, 伊藤義人. 膵臓における変化がNASH発癌に与える影響. 肝臓. 2023. 64. Supplement 1
-
山口寛二, 瀬古裕也, 伊藤義人. 肝臓病学の未来-ウイルス性肝炎から脂肪肝と肝がんの時代へ NAFLD/NASH 糖尿病治療のインパクト. 内科. 2019. 123. 5. 1137-1141-1141
-
伊藤義人, 山口寛二, 楳村敦詩, 西川太一朗, 瀬古裕也. Biomarkers/Scoring Systems of NAFLD/NASH. 日本臨床. 2019. 77. 5. 806-811
-
伊藤 義人, 山口 寛二, 楳村 敦詩, 西川 太一朗, 瀬古 裕也. Biomarkers/Scoring Systems of NAFLD/NASH. 日本臨床 = Japanese journal of clinical medicine. 2019. 77. 5. 806-811
-
山口 寛二, 瀬古 裕也, 伊藤 義人. 糖尿病治療のインパクト (特集 肝臓病学の未来 : ウイルス性肝炎から脂肪肝と肝がんの時代へ) -- (NAFLD/NASH). 内科 = Internal medicine : 臨床雑誌. 2019. 123. 5. 1137-1141
ｍore...
Association Membership(s) (2)：
Return to Previous Page
